Phibro Animal Health (NASDAQ:PAHC) Price Target Raised to $20.00

Phibro Animal Health (NASDAQ:PAHC) had its price objective hoisted by Barclays from $13.00 to $20.00 in a research report report published on Tuesday,Benzinga reports. They currently have an underweight rating on the stock.

Other equities research analysts also recently issued reports about the stock. Bank of America lifted their price target on shares of Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a research note on Friday, August 30th. JPMorgan Chase & Co. began coverage on shares of Phibro Animal Health in a research note on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 price target for the company. Three analysts have rated the stock with a sell rating, one has assigned a hold rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $16.50.

Phibro Animal Health Price Performance

PAHC stock opened at $24.46 on Tuesday. The firm has a market cap of $990.63 million, a price-to-earnings ratio of 56.89, a PEG ratio of 0.66 and a beta of 0.51. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81. Phibro Animal Health has a 12-month low of $9.49 and a 12-month high of $25.98. The company’s fifty day simple moving average is $22.79 and its 200 day simple moving average is $19.69.

Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Wednesday, August 28th. The company reported $0.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.34 by $0.07. The business had revenue of $273.16 million for the quarter, compared to analyst estimates of $262.44 million. Phibro Animal Health had a net margin of 1.67% and a return on equity of 21.59%. On average, analysts expect that Phibro Animal Health will post 1.59 earnings per share for the current year.

Phibro Animal Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th will be given a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 1.96%. The ex-dividend date of this dividend is Wednesday, November 27th. Phibro Animal Health’s payout ratio is presently 111.63%.

Insider Transactions at Phibro Animal Health

In other Phibro Animal Health news, Director E Thomas Corcoran bought 5,000 shares of the firm’s stock in a transaction dated Wednesday, September 4th. The stock was bought at an average cost of $20.02 per share, with a total value of $100,100.00. Following the completion of the transaction, the director now directly owns 25,000 shares in the company, valued at approximately $500,500. The trade was a 25.00 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. 50.07% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Phibro Animal Health

A number of institutional investors have recently added to or reduced their stakes in PAHC. CWM LLC grew its position in Phibro Animal Health by 89.8% in the 2nd quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after purchasing an additional 1,035 shares in the last quarter. nVerses Capital LLC bought a new stake in Phibro Animal Health in the 3rd quarter worth about $70,000. Quantbot Technologies LP bought a new stake in Phibro Animal Health in the 3rd quarter worth about $70,000. Summit Securities Group LLC bought a new stake in Phibro Animal Health in the 2nd quarter worth about $83,000. Finally, China Universal Asset Management Co. Ltd. grew its position in Phibro Animal Health by 63.7% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock worth $88,000 after purchasing an additional 1,522 shares in the last quarter. 99.34% of the stock is owned by institutional investors.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.